These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

167 related articles for article (PubMed ID: 33017615)

  • 1. Effect of Intracavernosal Injection of Prostaglandin E1 on Duration and Rigidity of Erection in Patients With Vasculogenic Erectile Dysfunction: Is It Dose Dependent?
    Bassiem MA; Ismail IY; Salem TA; El-Sakka AI
    Urology; 2021 Feb; 148():173-178. PubMed ID: 33017615
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Failure to attain stretched penile length after intracavernosal injection of a vasodilator agent is predictive of veno-occlusive dysfunction on penile duplex Doppler ultrasonography.
    Yafi FA; Libby RP; McCaslin IR; Sangkum P; Sikka SC; Hellstrom WJ
    Andrology; 2015 Sep; 3(5):919-23. PubMed ID: 26235901
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Comparison of intraurethral liposomal and intracavernosal prostaglandin-E1 in the management of erectile dysfunction.
    Engelhardt PF; Plas E; Hübner WA; Pflüger H
    Br J Urol; 1998 Mar; 81(3):441-4. PubMed ID: 9523667
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Diagnostic categorization of erectile dysfunction using duplex color doppler ultrasonography and significance of phentolamine redosing in abolishing false diagnosis of venous leak impotence: A single center experience.
    Ravikanth R
    Indian J Radiol Imaging; 2020; 30(3):344-353. PubMed ID: 33273769
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Relation between intracavernosal dose of prostaglandin Pge 1 and mean duration of erection in men with different underlying causes of erectile dysfunction.
    Bratus D; Hlebic G; Hajdinjak T
    Croat Med J; 2007 Feb; 48(1):76-80. PubMed ID: 17309142
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Why a combined intracavernosal injection with trimix and oral sildenafil is reliable therapy in the ultrasonographic evaluation of erectile dysfunction.
    Park JK; Park JS; Jeon SB; Cui WS; Kim SZ; Kang KK; Lee SW
    BJU Int; 2008 Sep; 102(8):993-7. PubMed ID: 18476965
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The long-term safety of alprostadil (prostaglandin-E1) in patients with erectile dysfunction. The European Alprostadil Study Group.
    Br J Urol; 1998 Oct; 82(4):538-43. PubMed ID: 9806184
    [TBL] [Abstract][Full Text] [Related]  

  • 8. An attempt to standardize the pharmacological diagnostic screening of vasculogenic impotence with prostaglandin E1.
    McMahon CG
    Int J Impot Res; 1995 Jun; 7(2):83-90. PubMed ID: 7496445
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The use of intracavernous injection and audiovisual sexual stimulation during real-time pharmacopenile doppler ultrasonography in vasculogenic erectile dysfunction.
    Tang J; Tang Y; Dai Y; Lu L; Jiang X
    Urol Int; 2013; 90(4):460-4. PubMed ID: 23548406
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Clinical and duplex US assessment of effects of sildenafil on cavernosal arteries of the penis: comparison with intracavernosal injection of vasoactive agents--initial experience.
    Copel L; Katz R; Blachar A; Sosna J; Sheiman RG
    Radiology; 2005 Dec; 237(3):986-91. PubMed ID: 16237136
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Methodology of penile isotope imaging. Evaluation].
    Timmermans L
    Acta Urol Belg; 1998 Mar; 66(1):13-7. PubMed ID: 9611353
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Dose adaptation during training of intracavernous self-injections of prostaglandin E1].
    Staerman F; Veilhan LA; Guiraud P; Coeurdacier P; Cipolla B; Lobel B
    Prog Urol; 1996; 6(4):564-8. PubMed ID: 8924934
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Erectile response to intracavernous injection of linsidomine in 38 impotent patients. Comparison with prostaglandin E1].
    Lemaire A; Buvat J
    Prog Urol; 1998 Jun; 8(3):388-91. PubMed ID: 9689672
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Quantitation of pharmacologically-induced penile erections: the value of radionuclide phallography in the objective evaluation of erectile haemodynamics.
    Siraj QH; Bomanji J; Akhtar MA; Rana MH; Sadiq M; Ahmed M
    Nucl Med Commun; 1990 Jun; 11(6):445-58. PubMed ID: 2385430
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Determinants of satisfactory rigidity after intracavernosal injection with prostaglandin E1 in men with erectile failure.
    Purvis K; Brekke I; Christiansen E
    Int J Impot Res; 1996 Mar; 8(1):9-16. PubMed ID: 8735188
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Prostaglandin E1 in the diagnosis and therapy of erectile disorders].
    Loran OB; Segal AS; Shcheplev PA
    Urol Nefrol (Mosk); 1995; (4):35-8. PubMed ID: 7571200
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Penile scarring with intracavernous injection therapy using prostaglandin E1: a risk factor analysis.
    Chen RN; Lakin MM; Montague DK; Ausmundson S
    J Urol; 1996 Jan; 155(1):138-40. PubMed ID: 7490812
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Does the positive intracavernous papaverine test always indicate a normal penile vascular system?
    Erdoğru T; Kadioğlu A; Cayan S; Tellaloğlu S
    Eur Urol; 1997; 31(3):323-8. PubMed ID: 9129924
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Usefulness of electromyography of the cavernous corpora (CC EMG) in the diagnosis of arterial erectile dysfunction.
    Virseda-Chamorro M; Lopez-Garcia-Moreno AM; Salinas-Casado J; Esteban-Fuertes M
    Int J Impot Res; 2012; 24(4):165-9. PubMed ID: 22551823
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Intracavernous self-injection of prostaglandin E1 in the treatment of erectile dysfunction.
    Kunelius P; Lukkarinen O
    Int J Impot Res; 1999 Feb; 11(1):21-4. PubMed ID: 10098949
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.